Tyra Biosciences Inc’s recent filing unveils that its Officer Tada Hiroomi acquired Company’s shares for reported $0.16 million on Nov 14 ’24. In the deal valued at $15.94 per share,10,107 shares were bought.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, RA CAPITAL MANAGEMENT, L.P. bought 1,220,681 shares, generating $19,836,066 in total proceeds. Upon buying the shares at $16.25, the Director now owns 8,697,956 shares.
Before that, Kjellson Nina S sold 52,491 shares. Tyra Biosciences Inc shares valued at $901,559 were divested by the Director at a price of $17.18 per share. As a result of the transaction, Kjellson Nina S now holds 451,629 shares, worth roughly $6.95 million.
BofA Securities upgraded its Tyra Biosciences Inc [TYRA] rating to a Buy from a a Neutral in a research note published on October 18, 2024; the price target was increased to $31 from $22. A number of analysts have revised their coverage, including Piper Sandler’s analysts, who began to cover the stock in mid August with a ‘”an Overweight”‘ rating. BofA Securities also remained covering TYRA and has decreased its forecast on December 15, 2023 with a “Neutral” recommendation from previously “Buy” rating. Wedbush started covering the stock on June 30, 2023. It rated TYRA as “an Outperform”.
Price Performance Review of TYRA
On Friday, Tyra Biosciences Inc [NASDAQ:TYRA] saw its stock fall -5.81% to $15.39. Over the last five days, the stock has lost -4.47%. Tyra Biosciences Inc shares have risen nearly 11.12% since the year began. Nevertheless, the stocks have risen 24.41% over the past one year. While a 52-week high of $29.60 was reached on 10/24/24, a 52-week low of $10.60 was recorded on 01/05/24. SMA at 50 days reached $21.31, while 200 days put it at $19.25.
Levels Of Support And Resistance For TYRA Stock
The 24-hour chart illustrates a support level at 14.83, which if violated will result in even more drops to 14.27. On the upside, there is a resistance level at 16.16. A further resistance level may holdings at 16.93. The Relative Strength Index (RSI) on the 14-day chart is 32.20, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.54, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 93.58%. Stochastics %K at 8.67% indicates the stock is a buying.
How much short interest is there in Tyra Biosciences Inc?
A steep rise in short interest was recorded in Tyra Biosciences Inc stocks on 2024-10-31, dropping by -0.63 million shares to a total of 1.76 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 2.38 million shares. There was a decline of -35.59%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on February 03, 2023 when Oppenheimer began covering the stock and recommended ‘”an Outperform”‘ rating along with a $17 price target.
